dimanche 15 novembre 2026
RechercherExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Source document· June 5, 2026

Samsara projects FY 2027 revenue of $2.005B-$2.013B while targeting 20% non-GAAP operating margin

View original at seekingalpha.com
Samsara projects FY 2027 revenue of $2.005B-$2.013B while targeting 20% non-GAAP operating margin Earnings Call Insights: Samsara (IOT) Q1 fiscal 2027 MANAGEMENT VIEW * "Samsara delivered a strong start to FY '27, with another quarter of durable and efficient growth" (CEO Sanjit Biswas), including: "We ended Q1 with ne…
Opening lines of the source · short snapshot: read the full document at the original

Ce que nous avons tiré de cette source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Samsara thinks it will be able to keep gross margins roughly flat for FY '27

    60% confidence
  • AI/cloud cost pressure is being mitigated via COGS-related optimizations and OPEX reallocation

    60% confidence
  • Samsara ended Q1 with nearly $2 billion in ARR, growing 30% year-over-year

    60% confidence
  • Q1 revenue was $479 million

    60% confidence
  • Waste Intelligence is monetized as additional SKUs

    60% confidence
  • Samsara expects to be GAAP profitable for Q2

    60% confidence
  • Q1 strength was driven by strength in emerging products

    60% confidence
  • Non-GTM functions may be roughly the same size, if not smaller

    60% confidence
  • At some point Samsara may offer a consumption-based pricing model for agents

    60% confidence
  • Q1 was Samsara's third consecutive quarter of GAAP profitability

    60% confidence
  • There is no unusual seasonality behind the modest-looking Q2 guidance step despite the raised full-year guide

    60% confidence
  • Samsara delivered a strong start to FY '27, with another quarter of durable and efficient growth

    60% confidence
  • Samsara signed 11 $1 million-plus net new ACV transactions in Q1

    60% confidence
  • Ground Intelligence is priced on a per mile basis

    60% confidence
  • Q1 was another quarter of accelerating growth and improved operating leverage

    60% confidence
  • Revenue grew 31% year-over-year in Q1

    60% confidence
  • Samsara raised the full-year non-GAAP operating margin target from 19% to 20%

    60% confidence
  • 96% of $100,000-plus ARR customers subscribe to two or more products

    60% confidence
  • For Q2, Samsara expects revenue between $482 million and $484 million

    60% confidence
  • The full-year guide raise is almost double the amount of the Q1 beat

    60% confidence
  • Samsara is emphasizing LTM (last 12 months) figures to reduce perceived volatility from large deal timing

    60% confidence
  • Q1 net new ARR was $101 million

    60% confidence
  • Samsara added $101 million in net new ARR in Q1

    60% confidence
  • There are no changes to hiring plans discussed on the last earnings call

    60% confidence
  • Non-GAAP operating margin was 19% in Q1

    60% confidence
  • Memory market visibility isn't as good as it has been in the past

    60% confidence
  • GAAP EPS would still be positive excluding the Motive arbitration award

    60% confidence
  • Maintenance is just where Samsara is going to start with Hertz

    60% confidence
  • Nothing about Q1 strength stands out as one-time in nature

    60% confidence
  • In May, Samsara gathered hundreds of public sector customers at Go Beyond event in Chicago, introducing Waste Intelligence, Ground Intelligence, and Ridership Management

    60% confidence
Ce que nous savons · l'intelligence derrière cette page
En direct du substrat
Ce que nous observons
Q4 2026 Biotech Catalyst Cluster: Late-Stage Data and PDUFA Dates Converge
Early-to-mid November 2026 is a dense run of clinical readouts and Q3 earnings at AHA, AASLD, ACR and ASH. Mid-cap biotechs (Vir, Mineralys, Arrowhead, Oryzon, Novartis, J&J) are reporting data that feeds into regulatory decisions. The next ones are the ivonescimab BLA (Nov 14) and the lorundrostat PDUFA (Dec 22), followed by ECLIPSE 2/3 and Maritime-1 readouts in Q1 2027. The list also includes an unrelated delisting track (EGM Nov 19, application Jan 25, 2027), and the facts have no AI or fintech content.
Notre lecture des données ›
Signaux que nous suivons
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Tendances que nous surveillons ›
Là où les sources divergent
Sources réconciliées : aucun conflit ouvert pour l'instant.
Nous signalons les conflits ouvertement ›
Vérifié récemment
✓ Vérifié avec la source d'origine
4,959
faits reliés à leur source, et nous signalons ceux qui ne tiennent pas.
101 entités suivies4,959 faits vérifiés avec la source5,585 documents sources archivés
Interrogez ces données → isubstrate.com
Samsara projects FY 2027 revenue of $2.005B-$2.013B while targeting 20% non-GAAP operating margin: Source | Via News | fr.via.news